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Background: Voluntary resistance exercise (RE) training increases muscle mass and strength
in patients with chronic obstructive pulmonary disease (COPD). Nonvolitional transcutaneous
neuromuscular electrical stimulation (NMES) may be an alternative strategy for reducing
ambulatory muscle weakness in patients unable to perform RE training, but little comparative
data are available. This study, therefore, investigated changes in muscle mRNA abundance of
a number of gene targets in response to a single bout of NMES compared with RE.
Methods: Twenty-six patients with stable COPD (15 male; FEV1, 43±18% predicted; age,
64±8 years; fat free mass index, 16.6±1.8 kg/m2) undertook 30 minutes of quadriceps NMES
(50 Hz, current at the limit of tolerance) or 5×30 maximal voluntary isokinetic knee
extensions. Vastus lateralis muscle biopsies were obtained at rest immediately before and
24 hours after intervention. Expression of 384 targeted mRNA transcripts was assessed by
real time TaqMan PCR. Signiﬁcant change in expression from baseline was determined using
the ΔΔCT method with a false discovery rate (FDR) of <5%.
Results: NMES and RE altered mRNA abundance of 18 and 68 genes, respectively (FDR
<5%), of which 14 genes were common to both interventions and of the same magnitude of
fold change. Biological functions of upregulated genes included inﬂammation, hypertrophy,
muscle protein turnover, and muscle growth, whilst downregulated genes included mitochon-
drial and cell signaling functions.
Conclusions: Compared with NMES, RE had a broader impact on mRNA abundance and,
therefore, appears to be the superior intervention for maximizing transcriptional responses in
the quadriceps of patients with COPD. However, if voluntary RE is not feasible in a clinical
setting, NMES by modifying expression of genes known to impact upon muscle mass and
strength may have a positive inﬂuence on muscle function.
Keywords: COPD, NMES, skeletal muscle, gene expression, resistance exercise
Introduction
Impaired skeletal muscle function is a common systemic feature of COPD and an
important contributor to morbidity and mortality.1,2 There is substantive evidence
demonstrating the beneﬁts of resistance exercise (RE) training in COPD,3–5 and it is
currently recommended that this modality of training should be incorporated into
pulmonary rehabilitation programs.6 However, not all patients with COPD are able to
perform conventional voluntary resistance training of sufﬁcient intensity to bring about
meaningful gains in muscle mass and strength, due to advanced deconditioning, acute
exacerbation, and associated dyspnoea or hospitalization. Transcutaneous neuromus-
cular electrical stimulation (NMES) is a nonvolitional means of evoking muscle
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contraction that places minimal demand on the cardiorespira-
tory system, and does not induce signiﬁcant dyspnoea.7,8 For
these reasons, NMES may be an effective strategy for the
maintenance or improvement of muscle function in settings
as above, where voluntary RE training cannot be performed.9
Despite eliciting low contractile forces during training
(typically below 15% of maximal voluntary isometric
strength10), clinical studies have suggested that NMES
increases muscle mass and strength in COPD.11,12 To date,
however, understanding of the training adaptations to NMES
at a muscle level, and how these compare to those elicited by
voluntary RE is limited. It is known that an unaccustomed
bout of voluntary RE in COPD causes a change in expres-
sion of a wide range of mRNA transcripts,13 but this infor-
mation is lacking for NMES, where it is likely that a smaller
muscle mass will be recruited.
This study investigated changes in the expression of
muscle mRNA transcripts 24 hours following a single bout
of NMES or RE in matched cohorts of patients with COPD.
Speciﬁcally, we investigated whether the abundance of gene
transcripts shown to be responsive to RE in healthy, young
volunteers14,15 followed similar patterns of change when
comparing NMES and RE, and whether the magnitude of
any change was similar for the two contraction modalities.
Methods
Subjects
Patients with a clinical diagnosis of COPD, conﬁrmed airﬂow
obstruction (FEV1<80% predicted, FEV1/FVC ratio <0.7)
and signiﬁcant self-reported exertional dyspnoea (MRC
Grade ≥3) were recruited from outpatient clinics, pulmonary
rehabilitation waiting lists, and previous research volunteers
at the University Hospitals of Leicester NHS Trust, UK. At
the time of recruitment, patients were free from exacerbation
and oral steroid medication for ≥4 weeks, had not attended
pulmonary rehabilitation for ≥1 year, and had no comorbid-
ities leading to signiﬁcant exercise limitations.
Experimental protocol
Matched cohorts of patients with COPD undertaking
NMES and RE were recruited to the study. Patients
attended baseline assessments to perform spirometry,
undergo body composition measures, and perform NMES
or RE familiarization a minimum of 1 week before the ﬁrst
biopsy visit. Resting biopsies were performed on the vas-
tus lateralis muscle using the micro-biopsy technique pre-
viously used in our laboratory.16 Tissue was snap frozen in
liquid nitrogen and stored for later analysis. After tissue
acquisition, a light dressing was applied to the biopsy site,
and a single exercise bout (either transcutaneous NMES or
voluntary RE of the quadriceps) was performed. Twenty-
four hours later, a second resting biopsy was performed at
least 2.5 cm from the previous biopsy site, thereby mini-
mizing confounding changes in mRNA abundance due to
tissue sampling.13,14,17 Previous work has shown expres-
sion of genes related to skeletal muscle mass regulation is
altered 24 hours post-RE in COPD and health.13,14
Subjects for this study were drawn from two cohorts who
undertook a NMES or RE intervention in otherwise identical
experimental designs. Groups were matched based on lung
function and body composition (Table 1). This study was
conducted in accordance with the Declaration of Helsinki;
Table 1 Patients’ baseline characteristics
Variable NMES Voluntary RE P
Males/females, n 7/6 8/5 0.691
Age, years 63.6 (9.1) 64.2 (7.0) 0.867
Height, m 1.61 (9) 1.65 (11) 0.351
Body mass, kg 66.4 (12.5) 65.4 (20.5) 0.883
BMI, kg/m2 25.6 (4.2) 23.7 (5.6) 0.341
FFMI, kg/m2 16.8 (1.7) 16.4 (2.0) 0.700
FEV1, l 1.02 (0.34) 1.02 (0.47) 0.996
FEV1, % predicted 45.5 (19.3) 40.3 (16.7) 0.476
FEV1/FVC 0.41 (0.10) 0.44 (0.13) 0.552
Smoking status (current/ex/never) 1/11/1 7/6/0 0.031
Pack years smoked 44.3 (23.5) 56.2 (35.8) 0.325
MRC grade 4 (3–4) 4 (3–4) 0.511
Notes: Values are mean (SD) except MRC Grade which is median (IQR).
Abbreviations: BMI, body mass index; FFMI, fat free mass index (by DEXA scan); FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; MRC Grade, Medical
Research Council dyspnoea scale; NMES, transcutaneous neuromuscular electrical stimulation; RE, resistance exercise.
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ethical approval was granted by the UK National Health
Service (NHS) Research Ethics Committee (REC) (NMES
Study: West Midlands REC, reference 10/H1208/73; RE
Study: Leicestershire, Northamptonshire and Rutland REC,
reference 05/Q2502/131), and participants provided written
informed consent.
Baseline assessments
Height and body mass in light clothing were measured
before body composition assessment using dual energy
x-ray absorptiometry (DEXA; Lunar Prodigy, GE,
Buckinghamshire, UK). Body Mass Index (BMI) was cal-
culated as: total body mass (kg)/height (m)2. Fat Free
Mass Index (FFMI) was calculated using the same equa-
tion, but with body mass replaced with whole-body lean
mass+whole-body bone mineral mass (kg). Spirometry
was performed using a portable spirometer in accordance
with British Thoracic Society guidelines.18
Exercise protocol
The NMES protocol employed a hand-held, battery pow-
ered device (Empi 300PV, MN, USA) connected to two
skin surface gel electrodes placed over the quadriceps (see
Supplementary materials for details). The protocol con-
sisted of 30 minutes of stimulation with a biphasic pulse
at 50 Hz (pulse duration 300 µs) made up of 15-second
duty cycles with 5-second rests. Patients self-selected sti-
mulation intensity and were encouraged to set the current
at the limit of tolerability. During familiarization, patients
underwent stimulation starting at minimum intensity (1
mA) and progressing to the self-determined limit of toler-
ance during a session lasting no longer than 10 minutes.
RE consisted of ﬁve sets of 30 maximal isokinetic knee
extensions at 180°/s with 1 minute rest between sets per-
formed on an isokinetic dynamometer (Cybex NORM II,
CSMi, Stoughton, USA). Patients were seated with hip
and knee ﬂexion of 90°. This protocol has previously
been shown to change quadriceps mRNA abundance in
COPD patients 24 hours following exercise.13
RNA extraction
RNAwas extracted from muscle samples using TRI Reagent
(Applied Biosystems/Life Technologies, Paisley, UK) and
reverse transcribed using SuperScript III (Life Technologies/
Invitrogen) to synthesize complimentary DNA (see
Supplementary materials). Complimentary DNAwas loaded
onto TaqMan 384 well custom Low Density Array (LDA)
microﬂuidic cards (Applied Biosystems/Life Technologies)
and 40 cycles of automated polymerase chain reaction
(PCR) performed on a TaqMan 7900HT Real-Time PCR
Instrument (Applied Biosystems, Paisley, UK).
Muscle mRNA expression
The abundance of mRNA was assessed using automated
384-well, LDA cards. The microﬂuidic cards were custom-
designed to target families of genes whose functions include
metabolic processes, mitochondria, diabetes, cell cycle/
growth/differentiation, inﬂammation, and immune
responses. Target selection was directed by data from two
studies that employed a similar isokinetic RE protocol to
that used in the current study. The ﬁrst study reported an
Affymetrix based analysis of tissue sampled at rest pre- and
24 hours-post resistance exercise in healthy volunteers.14
The second study highlighted gene expression changes fol-
lowing a similar bout of RE in young healthy volunteers
who had undergone a period of immobilization.15
Data analysis
Gene expression data were analyzed using the comparative
CT method (ΔΔCT), which permits relative quantiﬁcation of
the target gene transcript against an internal control gene
transcript.19 A suitable control gene (hydroxymethylbilane
synthase; HMBS) was selected that had stable CT values
across time points. Paired t-tests were used to identify
signiﬁcant change in expression of the target gene relative
to HMBS (ΔCT) from baseline to 24 hours, and the False
Discovery Rate (FDR) adjustment applied to control for
multiple comparisons using the R Statistical Package (R
Version 3.0.0, 2013–04-03, The R Foundation for
Statistical Computing). Expression values are presented as
fold change from baseline (2−ΔΔCT) and signiﬁcant within-
group change was deﬁned by a FDR <5%. Missing values
occurred where gene expression was below the limit of
detection after 40 cycles of PCR. A gene was excluded
from the analysis if there were more than two missing
data points. Between-group differences in physiological
variables were tested by t-test, Mann-Whitney U-test (ordi-
nal data), or Pearson Χ2 test (categorical data).
Results
Patient characteristics
Thirteen COPD patients received NMES and 13 patients
performed voluntary RE. There were no signiﬁcant dif-
ferences between the groups for baseline measures of
lung function, MRC grade, or body composition,
Dovepress Latimer et al
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although there was a signiﬁcant difference between the
groups for smoking history, with the RE group containing
more current smokers (Table 1).
Exercise bout
The mean (SD) peak torque generated during RE was 38
(±13) Nm, and the mean work done over ﬁve sets of 30
isometric knee extensions by the voluntary RE group was
2482 (±925) J. The mean (SD) electrical stimulation cur-
rent during NMES was 39.3 (±12.7) mA.
mRNA expression
Twenty-four hours after NMES, 18 mRNA transcripts
were signiﬁcantly changed in abundance, with 68 mRNA
transcripts signiﬁcantly changed in abundance 24
hours after RE (both FDR <5% compared to baseline,
Figure 1). Changes in abundance of 14 gene transcripts
were common to both NMES and RE,with no signiﬁcant
difference in the magnitude of fold change between groups
for these common genes (P>0.05). The within-group var-
iation in the response to NMES and RE is depicted in
Figure 2. Mean fold change values for all targets measured
are listed in Table S2 of the Supplementary materials.
The 14 transcripts signiﬁcantly inﬂuenced by both
NMES and RE perform a range of physiological roles,
which are detailed in Table 2, accompanied by fold
change data. Genes with physiological roles associated
with muscle hypertrophy, growth, repair, regeneration,
and anti-wasting, respectively (RUNX1, MYC, TIMP1,
FOS, and DYSF), were upregulated following both
NMES and RE. Other upregulated transcripts CTSL1,
CHI3L1, CDK2, and SOD2 have physiological roles
relating to protein breakdown, anti-inﬂammatory action,
cell cycle regulation, and antioxidant action, respec-
tively. Downregulated transcripts CCNG2, ATP2B2,
and RASGRP3 are inﬂuential in cell cycle/signaling
regulation. RASGRP3 also has a physiological role in
cancer, as does MN1, with both of these transcripts
downregulated after both interventions. Another tran-
script downregulated following both NMES and RE,
UQCRC1, codes for a mitochondrial sub-unit.
Discussion
This study describes altered expression of targeted mRNA
transcripts 24 hours after a 30 minute bout of transcuta-
neous electrically evoked muscle contraction or voluntary
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Figure 1 All genes signiﬁcantly altered in expression following either transcutaneous neuromuscular electrical stimulation (NMES; 18 genes) or resistance exercise (RE; 68
genes) with a false discovery rate (FDR) <5%. Data are expressed as fold change from baseline, where the baseline value equals 1 (dashed line). Boxes denote median and
interquartile range, whiskers are range. Magnitude of fold change (2−DDCT) are log values. Abbreviated gene names used in this ﬁgure are deﬁned in Table S1.
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muscle contraction in the quadriceps of matched cohorts of
patients with COPD. The major ﬁndings are 1) RE inﬂu-
enced a substantially broader range of transcripts than
NMES (68 vs 18, respectively); and 2) a smaller number
of transcripts (representing 14 genes) responded similarly
to the two interventions. Our conclusion is that the NMES
intervention employed in this study was not sufﬁcient to
stimulate the same breadth of transcriptional response
generated by maximal voluntary RE in COPD.
This is the ﬁrst study to examine the inﬂuence of
NMES on the expression of a broad range of mRNA
transcripts and, furthermore, to compare this response to
that following a bout of voluntary RE in well-matched
groups of COPD patients. There is existing evidence of
a transcriptional response to NMES in young non-weight
trained individuals,37 but this had not previously been
reported for patients with COPD. NMES has previously
been shown to inﬂuence phosphorylation of p70S6K,
a regulator of muscle protein synthesis,38 and inﬂuence
muscle ﬁber size,39 suggesting that repeated bouts of
NMES in COPD promote muscle ﬁber adaptation. More
is known about the molecular changes in muscle following
a bout of voluntary RE in COPD; expression of gene
transcripts with functions relating to muscle protein synth-
esis and breakdown, myogenesis, transcription factors, and
inﬂammation have previously been shown to respond to
a bout of isokinetic resistance exercise in COPD patients13
in a manner comparable to that shown in our study.
Breadth of transcriptional response to
NMES and RE
NMES was performed at the highest tolerable intensity in
order to maximize muscle ﬁber recruitment; however, the
narrower range of gene transcription responses following
NMES is likely to be a function of less muscle recruitment
during NMES compared to RE. This is supported by the
observation that the changes in mRNA abundance of the
14 common transcripts were similar between NMES and
RE. A limitation of this study is that muscle tension
development during NMES was not measured, but is
known to typically be below 15% of maximal voluntary
isometric force generation10 and might, therefore, be
assumed to have been considerably lower than that pro-
duced during RE.38
The contraction provoked by NMES does not follow
Henneman’s size principle40 of motor unit recruitment,
rather NMES depolarizes larger motor neurones ﬁrst,
thus preferentially activating fast-muscle ﬁbers (which
tend to be on the periphery of the muscle bundle41), or
may activate ﬁbers in a spatially determined manner
dependent on proximity to the skin-surface electrode.42
The genes differentially regulated by NMES may, there-
fore, have been inﬂuenced by the type of muscle
ﬁber recruited during electrical stimulation; unlike RE,
where all ﬁber types are likely to have been recruited.
NMES improves muscle strength and function across
a range of stimulation frequencies,9,11,43–47 with efﬁcacy
dependent on stimulation intensity,38 which determines
contraction force. Stimulation intensity is limited by the
tolerance of the individual and, in healthy individuals,
there have been reports of pain during stimulation.48 In
health there have also been reports of NMES causing
muscle damage and delayed onset soreness,48–50 compar-
able to that caused by eccentric RE,10,51 despite generating
lower force.52 However, NMES protocols utilized in
chronic disease rehabilitation, that generally elicit lower
contraction forces, appear to be well tolerated43 and sig-
niﬁcantly increase muscle strength and mass, even when
generating a force as low as 13% of maximal voluntary
contraction.38
Common responses
The transcriptional response of muscle to both NMES and
REwas similar for 14 gene transcripts (Figure 2 and Table 2),
whether these changes reﬂect mutual type II muscle
ﬁber recruitment is unknown. Functions of shared
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Figure 2 Heatmap demonstrating individual variation in response to transcuta-
neous neuromuscular electrical stimulation (NMES) and resistance exercise (RE) for
the 14 transcripts that were signiﬁcantly inﬂuenced by both interventions. Scale
capped at 8-fold change, baseline value =1. Abbreviated gene names used in this
ﬁgure are deﬁned in Table S1.
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upregulated transcripts were associated with muscle growth,
repair and regeneration,anti-inﬂammatory/antioxidant
action, and protein breakdown. In addition, there was com-
mon downregulation of gene transcripts associated with cell
cycle, cancer, and mitochondrial function. Following both
interventions, the most markedly upregulated mRNAs were
CHI3L1 and RUNX1. CHI3L1 (chitinase-3-like protein 1)
gene expression is known to be induced by contractile
activity,53 and the protein is associated with myoblast
proliferation53 and inhibition of the inﬂammatory
response.20 RUNX1 (runt-related transcription factor 1) may
be protective against disuse atrophy,21 and there is
a pronounced increase in expression when muscle is exer-
cised after a period of immobilization.54 RUNX1may also be
a target ofMYOD1, which regulates myogenesis and skeletal
muscle differentiation.55 Whilst the inﬂuence of any indivi-
dual gene on muscle function or architecture is likely to be
small, the strong induction of these two genes after both
NMES and RE supports the notion that both interventions
are inﬂuencing muscle cells towards a pro-growth state. We
performed a pathway analysis on the 14 common genes using
Ingenuity Pathway Analysis (IPA; QIAGEN, Redwood City,
CA, USA www.qiagen.com/ingenuity). Due to the small
number of transcripts, only a single cellular function (Cell
Death and Survival) was identiﬁed by IPA as being signiﬁ-
cantly altered, with a relatively low level of signiﬁcance
(Figures S1 and S2).
The fully quantitative and highly sensitive RT-PCR
technique employed in this study allows characterization
of a wide range of expression values. Furthermore, the
Table 2 List of transcripts signiﬁcantly altered in expression following a bout of NMES or RE
Target
name
Full name Physiological role NMES RE
Fold
change
FDR
%
Fold
change
FDR
%
(2−ΔΔCT) (2
−ΔΔC
T)
Increased after both electrical stimulation and resistance exercise
CHI3L1 chitinase 3-like 1 Protects muscle against inﬂammation20 84.4 <0.001 59.3 0.003
RUNX1 runt-related transcription factor 1 Upregulated by exercise. May prevent muscle
wasting21,22
15.7 0.005 12.6 0.009
MYC v-myc avian myelocytomatosis viral
oncogene homolog
Muscle growth via ribosomal biogenesis23 10.3 0.011 11.5 0.006
FOS FBJ murine osteosarcoma viral
oncogene homolog
Transcription factor for pro-hypertrophy
genes24,25
17.6 0.011 8.7 0.029
TIMP1 TIMP metallopeptidase inhibitor 1 Promotes cell proliferation, inhibits apoptosis.
May promote angiogenesis26,27
16.7 0.024 11.2 0.007
SOD2 superoxide dismutase 2,
mitochondrial
Antioxidant28 3.6 0.029 3.6 0.036
DYSF dysferlin Muscle repair/regeneration29 6.2 0.033 4.2 0.013
CDK2 cyclin-dependent kinase 2 Cell cycle regulation30 3.2 0.033 3.1 0.025
CTSL cathepsin L Protein breakdown31 5.2 0.027 5.3 0.003
Downregulated after both electrical stimulation and resistance exercise
MN1 meningioma (disrupted in balanced
translocation) 1
Cancer32 0.4 0.024 0.6 0.01
CCNG2 cyclin G2 Cell cycle33 0.6 0.024 0.6 0.016
RASGRP3 RAS guanyl releasing protein 3 Cell signaling34 0.6 0.024 0.6 0.036
ATP2B2 ATPase, Ca++ transporting, plasma
membrane 2
ATP Pump controlling intracellular calcium
level35
0.4 0.024 0.4 0.003
UQCRC1 ubiquinol-cytochrome c reductase
core protein I
Mitochondrial sub-unit36 0.6 0.027 0.7 0.025
Notes: False discovery rate (FDR) <5% is the threshold for signiﬁcance. Between group differences in fold change all P>0.05. 2−ΔΔCT, mean fold change from baseline
corrected for expression of the internal control gene (HMBS).
Abbreviations: NMES, transcutaneous neuromuscular electrical stimulation; RE, resistance exercise.
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intervention groups were well matched for age, gender,
and body composition, and adhered to a carefully planned
study day protocol. There were more current smokers in
the RE group. There is some evidence that cigarette smoke
exposure may downregulate resting muscle protein synth-
esis rates in humans,56 and inhibit muscle signaling path-
ways in mice;57 however, in the current study there was no
difference in fat-free mass between groups at baseline, and
it was the RE group (who had the greater cigarette smoke
exposure) who demonstrated the largest mRNA response
to the interventions used in this study. Therefore, we are
conﬁdent that the differences in gene expression observed
after the two interventions were as a result of the contrac-
tion mode, rather than a characteristic of the two groups.
We have considered the likely inﬂuence of the prior biopsy
procedure on mRNA abundance 24 hours after muscle
contraction. Evidence from healthy subjects in our own
laboratory14 and other’s17 demonstrate no transcriptional
changes in skeletal muscle after serial needle biopsy pro-
cedures in the absence of exercise, thus we are conﬁdent
that the mRNA responses reported here are a reaction to
muscle contraction, rather than the biopsy procedure
per se.
Conclusion
In conclusion, a novelty of this study is that it demon-
strates a single bout of RE inﬂuences the expression of
a far wider selection of genes than a single bout of NMES.
However, there is a commonality of response for a small
sub-set of gene transcripts. Based on our evidence, volun-
tary RE would appear to be the preferable mode of exer-
cise intervention to elicit the largest muscle transcriptional
response in stable COPD patients. However, NMES within
the limits of comfort for patients does elicit a pro-growth
transcriptional response. Further work is warranted to
investigate the effect of repeated bouts of NMES and RE
on molecular responses and physiological adaptation to
a chronic intervention.
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